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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 207 (FGE.207): 
Consideration of genotoxic potential for one branched-chain aliphatic 
acyclic α,β-unsaturated 2-alkylated aldehyde with additional double-bonds, 
from subgroup 1.1.2 of FGE.19 and four alicyclic aldehydes with the α,β-
unsaturation in a side-chain, from subgroup 2.1 of FGE.19, which are 
considered to be covered by the one substance of subgroup 1.1.2, by EFSA
1
 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to evaluate the genotoxic potential of one flavouring substance, 2,6-dimethyl-2,5,7-
octatriene-1-ol acetate [FL-no: 09.931], from subgroup 1.1.2 of FGE.19, which is considered to be 
representative for four substances, 12-beta-santalen-14-ol [FL-no: 02.216], 12-alpha-santalen-14-ol [FL-no: 
02.217], santalyl acetate [FL-no: 09.034] and santalyl phenylacetate [FL-no: 09.712], from subgroup 2.1 of 
FGE.19. The Flavour Industry has provided genotoxicity studies for the representative substance 2,6-dimethyl-
2,5,7-octatriene-1-ol acetate [FL-no: 09.931] and these data are considered by EFSA to be representative for the 
four substances [FL-no: 02.216, 02.217, 09.034 and 09.712]. Based on the new data, the Panel concluded that 
2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] from FGE.19 subgroup 1.1.2 does not give rise to 
concern with respect to genotoxicity and can accordingly be evaluated using the Procedure. This conclusion can 
also be applied to the four substances 12-beta-santalen-14-ol [FL-no: 02.216], 12-alpha-santalen-14-ol [FL-no: 
02.217], santalyl acetate [FL-no: 09.034] and santalyl phenylacetate [FL-no: 09.712] from FGE.19 subgroup 2.1 
for which 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] is representative. 
© European Food Safety Authority, 2013 
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Jany, Martine Kolf-Clauw, Catherine Leclercq, Wim Mennes, Maria Rosaria Milana, Iona Pratt, Kettil Svensson, Maria de 
Fatima Tavares Pocas, Fidel Toldra, Detlef Wölfle. Correspondence: cef@efsa-europa.eu. 
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and Kim Rygaard Nielsen for the support provided to the formulation of this scientific opinion. 
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SUMMARY 
Following a request from the European Commission the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (CEF Panel) was asked to deliver a scientific opinion on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member states. In particular, the Panel was asked to evaluate flavouring substances using the 
Procedure as referred to in the Commission Regulation (EC) No 1565/2000. 
The present Flavouring Group Evaluation 207 (FGE.207), corresponding to subgroup 2.1 of FGE.19, 
concerns the evaluation of genotoxicity data submitted on one α,β-unsaturated flavouring substance, 
2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931], from subgroup 1.1.2 of FGE.19 
(FGE.201), which is considered to be representative for four substances, 12-beta-santalen-14-ol [FL-
no: 02.216], 12-alpha-santalen-14-ol [FL-no: 02.217], santalyl acetate [FL-no: 09.034] and santalyl 
phenylacetate [FL-no: 09.712], from subgroup 2.1 of FGE.19. 
The α,β-unsaturated carbonyl structure is a structural alert for genotoxicity and the data on 
genotoxicity previously available for these FGE.19 subgroup 2.1 substances or structurally related 
flavouring substances did not rule out the concern for genotoxicity.  
The Flavour Industry has provided new genotoxicity data for 2,6-dimethyl-2,5,7-octatriene-1-ol 
acetate [FL-no: 09.931] from subgroup 1.1.2 of FGE.19 (FGE.201), requested in FGE.201. These data 
are considered by the Panel to be representative for the four substances [FL-no: 02.216, 02.217, 
09.034 and 09.712] from FGE.19 subgroup 2.1 due to the fact that all five substances have the α,β-
unsaturation in an aliphatic side-chain and are methylated in the α-position of the α,β-unsaturation.  
Based on the new data, the Panel concluded that 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 
09.931] does not give rise to concern with respect to genotoxicity and accordingly it can be evaluated 
through the Procedure. This conclusion can also be applied to the four substances 12-beta-santalen-
14-ol [FL-no: 02.216], 12-alpha-santalen-14-ol [FL-no: 02.217], santalyl acetate [FL-no: 09.034] and 
santalyl phenylacetate [FL-no: 09.712] from FGE.19 subgroup 2.1 for which 2,6-dimethyl-2,5,7-
octatriene-1-ol acetate [FL-no: 09.931] is representative. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The use of flavourings is regulated under Regulation (EC) No 1334/2008 of the European Parliament 
and Council of 16 December 2008 (EC, 2008) on flavourings and certain food ingredients with 
flavouring properties for use in and on foods. On the basis of Article 9(a) of this Regulation, an 
evaluation and approval are required for flavouring substances. 
The Union list of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/2012 (EC, 2012). The list contains flavouring substances for which the 
scientific evaluation should be completed in accordance with Commission Regulation (EC) No 
1565/2000 (EC, 2000). 
EFSA has evaluated 11 flavouring substances, which correspond to subgroup 1.1.2 of FGE.19, in its 
evaluation of the flavouring group 201 (FGE.201). The opinion was adopted on 25 September 2008. 
EFSA concluded that a genotoxic potential of the 11 α,β-unsaturated aldehydes and alcohol and 
related esters in the present FGE.201 could not be ruled out. 
Information on one representative material 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] 
has now been submitted by the European Flavour Association. This information is intended to cover 
also the re-evaluation of the following four substances from FGR.19 subgroup 2.1 (FGE.207): 
 12-beta-Santalen-14-ol [FL-no: 02.216] 
 12-alpha-Santalen-14-ol [FL-no: 02.217] 
 Santalyl acetate [FL-no: 09.034] 
 Santalyl phenylacetate [FL-no: 09.712]  
The Commission asks EFSA to evaluate this new information and depending on the outcome proceed 
to the full evaluation of the flavouring substances. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Commission requests the European Food Safety Authority to carry out a safety 
assessment on the following five substances: 12-beta-santalen-14-ol [FL-no: 02.216], 12-alpha-
santalen-14-ol [FL-no: 02.217], santalyl acetate [FL-no: 09.034], santalyl phenylacetate [FL-no: 
09.712] and 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931], in accordance with 
Commission Regulation (EC) No 1565/2000. 
ASSESSMENT 
1. History 
Flavouring Group Evaluation 19 (FGE.19) contains 360 flavouring substances from the EU Register 
being α,β-unsaturated aldehydes or ketones and precursors which could give rise to such carbonyl 
substances via hydrolysis and / or oxidation (EFSA, 2008a). 
The α,β-unsaturated aldehyde and ketone structures are structural alerts for genotoxicity. The Panel 
noted that there were limited genotoxicity data on these flavouring substances but that positive 
genotoxicity studies were identified for some substances in the group. 
The α,β-unsaturated carbonyls were subdivided into subgroups on the basis of structural similarity 
(EFSA, 2008a). In an attempt to decide which of the substances could go through the Procedure, a 
(quantitative) structure-activity relationship ((Q)SAR) prediction of the genotoxicity of these 
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substances was undertaken considering a number of models (DEREKfW, TOPKAT, DTU-NFI-
MultiCASE Models and ISS-Local Models, (Gry et al., 2007)). 
The Panel noted that for most of these models internal and external validation has been performed but 
considered that the outcome of these validations was not always extensive enough to appreciate the 
validity of the predictions of these models for these α,β-unsaturated carbonyls. Therefore, the Panel 
considered it inappropriate to totally rely on (Q)SAR predictions at this point in time and decided not 
to take substances through the Procedure based on negative (Q)SAR predictions only. 
The Panel took note of the (Q)SAR predictions by using two ISS Local Models (Benigni and Netzeva, 
2007a; Benigni and Netzeva, 2007b) and four DTU-NFI MultiCASE Models (Gry et al., 2007; 
Nikolov et al., 2007) and the fact that there are available data on genotoxicity, in vitro and in vivo, as 
well as data on carcinogenicity for several substances. Based on these data the Panel decided that 15 
subgroups (1.1.1, 1.2.1, 1.2.2, 1.2.3, 2.1, 2.2, 2.3, 2.5, 3.2, 4.3, 4.5, 4.6, 5.1, 5.2 and 5.3) (EFSA, 
2008a) could not be evaluated through the Procedure due to concern with respect to genotoxicity. 
Corresponding to these subgroups, 15 Flavouring Group Evaluations (FGEs) were established, 
FGE.200, 204, 205, 206, 207, 208, 209, 211, 215, 219, 221, 222, 223, 224 and 225). 
For 11 subgroups the Panel decided, based on the available genotoxicity data and (Q)SAR predictions, 
that a further scrutiny of the data should take place before requesting additional data from the 
Flavouring Industry on genotoxicity. These subgroups were evaluated in FGE.201, 202, 203, 210, 212, 
213, 214, 216, 217, 218 and 220. For the substances in FGE.202, 214 and 218 it was concluded that a 
genotoxic potential could be ruled out and accordingly these substances will be evaluated using the 
Procedure. For all or some of the substances in the remaining FGEs, FGE.201, 203, 210, 212, 213, 
216, 217 and 220, the genotoxic potential could not be ruled out. 
To ease the data retrieval of the large number of structurally related α,β-unsaturated substances in the 
different subgroups for which additional data are requested, EFSA has worked out a list of 
representative substances for each subgroup (EFSA, 2008b). Likewise an EFSA genotoxicity expert 
group has worked out a test strategy to be followed in the data retrieval for these substances (EFSA, 
2008c).  
The Flavouring Industry has been requested to submit additional genotoxicity data according to the list 
of representative substances and test strategy for each subgroup.  
The Flavouring Industry has now submitted additional data and the present FGE concerns the 
evaluation of some of these data requested on genotoxicity. 
2. Presentation of the Substances in the Flavouring Group 207 
2.1. Description 
The present Flavouring Group Evaluation 207 (FGE.207), corresponding to subgroup 2.1 of FGE.19, 
concerns three α,β-unsaturated alicyclic alcohols, p-mentha-1,8(10)-dien-9-ol [FL-no: 02.122], 12-
beta-santalen-14-ol [FL-no: 02.216] and 12-alpha-santalen-14-ol [FL-no: 02.217], and three esters, 
santalyl acetate [FL-no: 09.034], santalyl phenylacetate [FL-no: 09.712] and p-mentha-1,8(10)-dien-9-
yl acetate [FL-no: 09.809], all with the α,β-unsaturation in a side-chain.  
The α,β-unsaturated aldehyde and ketone structure is a structural alert for genotoxicity (EFSA, 2008a) 
and the data on genotoxicity previously available did not rule out this concern for genotoxicity. 
For four of these six precursors for α,β-unsaturated alicyclic aldehydes [FL-no: 02.216, 02.217, 09.034 
and 09.712], the Panel has identified one structurally related substance in subgroup 1.1.2 of FGE.19 
(FGE.201), 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931]. This substance [FL-no: 
09.931] from subgroup 1.1.2 is considered representative for the four substances [FL-no: 02.216, 
02.217, 09.034 and 09.712] from FGE.19 subgroup 2.1 (FGE.207) and accordingly, if the genotoxicity 
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data provided for [FL-no: 09.931] can rule out the genotoxicity concern for this substance, the four 
substances [FL-no: 02.216, 02.217, 09.034 and 09.712] in FGE.19 subgroup 2.1 (FGE.207) can also 
be cleared for genotoxicity concern. For the remaining alcohol and ester in subgroup 2.1, p-mentha-
1,8(10)-dien-9-ol [FL-no: 02.122] and p-mentha-1,8(10)-dien-9-yl acetate [FL-no: 09.809], the Panel 
concluded that they could not be represented by the substance [FL-no: 09.931] from subgroup 1.1.2, 
but the Panel did find that the chemical structure of the two substances [FL-no: 02.122 and 09.809] 
allowed for a read across between genotoxicity data for the two substances and accordingly the 
Flavour Industry was requested to submit data for either the alcohol or the ester. The structures of the 
six substances from FGE.19 subgroup 2.1 (FGE.207) and the one representative substance [FL-no: 
09.931], from FGE.19 subgroup 1.1.2, originally evaluated in FGE.201, are shown in Table 2.  
Two of the substances from subgroup 2.1 [FL-no: 09.034 and 09.712] have previously been evaluated 
by the JECFA at their 59
th
 meeting (JECFA, 2002a; JECFA, 2003) and the one representative 
substance from subgroup 1.1.2 has been evaluated at their 61
st
 meeting (JECFA, 2004a; JECFA, 
2004b). A summary of their current evaluation status by the JECFA and the outcome of this 
consideration is presented in Table 3. 
2.2. Representative Substance for Subgroup 2.1 
For four [FL-no: 02.216, 02.217, 09.034 and 09.712] of the substances in subgroup 2.1 of FGE.19, the 
Panel has identified one structurally related substance [FL-no: 09.931] in subgroup 1.1.2 of FGE.19 
(FGE.201). This substance from subgroup 1.1.2, 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 
09.931], is considered adequate as representative for the four substances [FL-no: 02.216, 02.217, 
09.034 and 09.712] from subgroup 2.1. Accordingly, the Flavour Industry was requested to submit 
genotoxicity data for the representative substance from subgroup 1.1.2 in accordance with the test 
strategy (EFSA, 2008c). The chemical structures of the four substances [FL-no: 02.216, 02.217, 
09.034 and 09.712] from subgroup 2.1 and the one representative substance [FL-no: 09.931] from 
subgroup 1.1.2 are shown in Table 1.  
Table 1:  The Four Substances from Subgroup 2.1 and the Representative Substance of these   
FL-no  
JECFA-no  
EU Register name  Structural formula  FEMA no  
CoE no  
CAS no  
EFSA conclusion 
02.216 12-beta-Santalen-14-ol 
OH
 
3006 
74 
77-42-9 
[FL-no: 02.216] can 
be covered by [FL-
no: 09.931]. 
02.217 12-alpha-Santalen-14-ol 
OH
 
3006 
74 
115-71-9 
[FL-no: 02.217] can 
be covered by [FL-
no: 09.931]. 
09.034 
985 
Santalyl acetate 
O
O
O
O
 
3007 
224 
1323-00-8 
[FL-no: 09.034] can 
be covered by [FL-
no: 09.931]. 
09.712 
1022 
Santalyl phenylacetate 
O
O
O
O
 
3008 
239 
1323-75-7 
[FL-no: 09.712] can 
be covered by [FL-
no: 09.931]. 
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Table 1:  The Four Substances from Subgroup 2.1 and the Representative Substance of these   
FL-no  
JECFA-no  
EU Register name  Structural formula  FEMA no  
CoE no  
CAS no  
EFSA conclusion 
09.931 
1226 
2,6-Dimethyl-2,5,7-octatriene-
1-ol acetate 
O
O
 
3886 
- 
999999-91-
4 
[FL-no: 09.931] 
(subgroup 1.1.2) 
can represent [FL-
no: 02.216, 02.217, 
09.034 and 09.712]. 
3. Additional Genotoxicity Data Submitted for Subgroup 2.1 and Subgroup 1.1.2 
The Industry has submitted data concerning genotoxicity studies (EFFA, 2012) for one substance 2,6-
dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] of FGE.19 subgroup 1.1.2 (FGE.201). These 
data will cover four substances [FL-no: 02.216, 02.217, 09.034 and 09.712] from FGE.19 subgroup 
2.1, the present FGE.207.  
The new data submitted for 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] covers in vitro 
assays in bacteria and mammalian cell systems. 
3.1. In vitro Data 
3.1.1. Bacterial Reverse Mutation Assay 
An Ames assay was conducted in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 
and TA102 to assess the mutagenicity of 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931], 
both in the absence and in the presence of metabolic activation by S9-mix (from livers of rats induced 
with Aroclor 1254), in three experiments (King, 2000). An initial experiment was carried out in the 
absence and presence of S9-mix in the five strains, using final concentrations of 2,6-dimethyl-2,5,7-
octatriene-1-ol acetate at 5 - 5000 μg/plate in the presence of S9-mix activation and 5 - 1500 μg/plate 
in the absence of S9-mix, plus negative (solvent) and positive controls. The standard plate 
incorporation assay was used. Evidence of toxicity, in terms of a decrease in revertant count, was 
apparent on all plates treated at 500 μg/plate and above in the absence of S9-mix. In the presence of 
S9-mix, the test article was toxic at concentrations of 1500 μg/plate and above for strains TA1537 and 
TA102, and at 5000 μg/plate for strains TA98, TA100, and TA1535. In all cases revertant counts were 
obtained from at least four different concentrations, and so these data were considered valid for 
mutation assessment. In the absence of S9-mix activation, no statistically significant increases in 
revertant numbers were observed in any of the test strains. In the presence of S9-mix activation no 
statistically significant increases in revertant numbers were observed for strains TA98, TA100, 
TA1535 or TA1537, but very small increases in revertant numbers were observed in strain TA102 at 
15 and 50 μg/plate which, although statistically significant (p ≤ 0.05), amounted to only 1.17-fold and 
1.18-fold increases over background, respectively. Furthermore, no increases were observed at the 
higher test concentrations of 150 and 500 μg/plate. 
In a second confirmatory experiment using the same conditions, no statistically significant increases in 
revertant numbers were observed at any concentration in any of the strains, either in the presence or 
absence of S9-mix activation. To further investigate the potential mutagenic effect in strain TA102 in 
the presence of S9-mix activation, a third experiment was conducted in that strain only. No 
statistically significant increases in revertant numbers were observed at any concentration tested. 
On this basis, the very small increases seen in only a single experiment at the two lower test 
concentrations in the presence of S9-mix activation in strain TA102 were not reproducible or 
concentration-related, and were therefore considered to be chance occurrences and not related to 
treatment with 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] (King, 2000). It was 
concluded that 2,6-dimethyl-2,5,7-octatriene-1-ol acetate did not induce mutation in five histidine-
requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of S. typhimurium when tested under 
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the conditions of this study. These conditions included treatments at concentrations up to either the 
limit of toxicity or 5000 μg/plate (the maximum recommended concentration, according to current 
regulatory guidelines), in the absence and in the presence of a rat liver metabolic activation system 
(S9-mix). 
3.1.2. Micronucleus Assays 
2,6-Dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] was assayed for the induction of 
chromosome damage and potential aneugenicity in mammalian cells in vitro by examining the effect 
of compound treatment on the frequency of micronuclei in cultured human peripheral blood 
lymphocytes (whole blood cultures pooled from two healthy male volunteers in two separate 
experiments) treated in the absence and presence of a metabolising system (S9-mix) from livers of rats 
induced with Aroclor 1254 (Whitwell, 2012). 
2,6-Dimethyl-2,5,7-octatriene-1-ol acetate was added at 48 hours following culture initiation 
(stimulation by phytohaemagglutinin) either for 3 hours treatment in the absence or presence of S9-
mix plus 21 hours recovery, or for 24 hours treatment in the absence of S9-mix without recovery. 
Cytochalasin B (6 μg/ml) was added at the start of the 24-hour continuous treatment, or at the start of 
the 21-hour recovery periods following the 3-hour treatments, in order to block cytokinesis and 
generate binucleate cells for analysis. It remained in the cultures until they were harvested 24 hours 
after the start of treatment. A preliminary range-finding experiment had been conducted with and 
without S9-mix treatment in order to determine the effect of treatment upon Replication Index (RI), 
which was used as a basis for choosing a range of concentrations to be evaluated in Experiments 1 and 
2. 
In all of the different treatment conditions and separate experiments, frequencies of micronucleated 
binucleate cells (MNBN) were normal in negative controls and were significantly increased by 
treatment with the positive control chemical. 
In Experiment 1, all three different treatment conditions described above were investigated. In the first 
treatment condition, 2,6-dimethyl-2,5,7-octatriene-1-ol acetate was added for 3 hours in the absence of 
S9-mix at concentrations of 70, 85, 100 or 120 μg/mL along with positive and negative controls, 
followed by 21 hours recovery. No significant increases in the frequency of MNBN were observed 
relative to concurrent vehicle controls at any of the concentrations analysed. Furthermore, the MNBN 
cell frequencies in all treated cultures under this treatment condition fell within the 95
th
 percentile of 
the normal range. 
In the second treatment condition, following 24 hours continuous treatment at 20, 40 or 60 μg/mL in 
the absence of S9-mix without recovery, no increases in the frequency of MNBN cells were obtained 
that were significantly higher (p ≤ 0.05) than those observed in concurrent controls. Furthermore, the 
MNBN cell frequencies in all treated cultures under this treatment condition fell within the 95
th
 
percentile of the normal range. 
In the third treatment condition, following 3 hours treatment with 2,6-dimethyl-2,5,7-octatriene-1-ol 
acetate at concentrations of 120, 140, 180 or 225 μg/mL in the presence of S9-mix, followed by 21 
hours recovery, the frequency of MNBN cells were significantly higher (p ≤ 0.05) than concurrent 
controls at the top concentration analysed. This concentration induced a 57 % mean level of 
cytotoxicity, which is close to the recommended upper limit for this test procedure. Furthermore, 
increases in the frequency of MNBN cells were only seen in one replicate (A) where only 394 
binucleate cells could be analysed for this test concentration, where cytotoxicity actually exceeded 60 
%, and where examination of the slides indicated a concentration-related effect on cells without intact 
cytoplasm. This may have resulted in an underestimation of the cytotoxicity, but it was not observed in 
the other replicate culture (B). 
In Experiment 2, the weak induction of micronuclei that was observed in Experiment 1 in the presence 
of S9-mix was further investigated. Following treatment for 3 hours followed by 21 hours recovery in 
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the presence of S9-mix with 2,6-dimethyl-2,5,7-octatriene-1-ol acetate at concentrations of 119.2, 180, 
250 or 290 μg/mL, which induced 5 %, 19 %, 39 % and 54 % cytotoxicity, respectively, small but 
statistically significant (p ≤ 0.05) increases in MNBN cell frequencies were observed at the lowest and 
highest concentrations analysed. At the highest concentration analysed only a single replicate culture 
gave MNBN cell frequencies that exceeded normal historical control values, and it is also noteworthy 
that the vehicle control frequency was quite low for this particular experiment which might have 
contributed to the test outcome. Furthermore, additional analysis of spare slides from the replicate 
cultures at the lowest and highest concentrations analysed resulted in the overall micronucleus 
frequencies falling within normal ranges. On this basis, the weak statistical significance observed in 
the first experiment was not reproduced at higher concentrations and similar levels of toxicity, and was 
therefore not considered to be of biological relevance. 
In conclusion, 2,6-dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] was not considered to 
demonstrate induction of micronuclei in a robust study that achieved required levels of toxicity 
(Whitwell, 2012). 
4. Conclusion 
2,6-Dimethyl-2,5,7-octatriene-1-ol acetate [FL-no: 09.931] did not induce any biologically significant 
increases in bacterial mutation when evaluated in an Ames test in the presence and absence of S9 
metabolic activation. It did induce weak genotoxic effects in the in vitro micronucleus assay in an 
initial experiment in the presence of S9-mix at the highest concentration only. In a second experiment, 
although statistically significant increases were observed at the lowest and highest concentrations 
tested, these increases fell within the historical control range for the testing laboratory, and were not 
considered to be biologically important. The Panel therefore concluded that 2,6-dimethyl-2,5,7-
octatriene-1-ol acetate [FL-no: 09.931], from subgroup 1.1.2 of FGE.19 (FGE.201), does not give rise 
to concern with respect to genotoxicity and can accordingly be evaluated through the Procedure. 
Furthermore, as 2,6-dimethyl-2,5,7-octatriene-1-ol acetate is considered representative for the four 
precursors for α,β-unsaturated alicyclic aldehydes [FL-no: 02.216, 02.217, 09.034 and 09.712] from 
subgroup 2.1 of FGE.19 (FGE.207), the genotoxicity concern can also be lifted for these four 
substances and accordingly they can also be evaluated through the Procedure as well. 
 
Flavouring Group Evaluation 207 
 
EFSA Journal 2013;11(5):3228 10 
SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 207  
Table 2:  Specification Summary (JECFA, 2002b) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
02.122 
 
p-Mentha-1,8(10)-dien-9-ol  
HO
 
FDA 
10239 
3269-90-7 
Liquid 
C10H16O 
152.24 
Practically insoluble or 
insoluble 
Freely soluble 
104 (1 hPa) 
 
MS 
95 % 
1.494-1.500 
0.962-0.968 
02.216 
 
12-beta-Santalen-14-ol 
OH
 
3006 
74 
77-42-9 
Liquid 
C15H24O 
220.36 
Insoluble 
Soluble 
129 (5.3 hPa) 
 
MS 
95 % 
1.498-1.509 
0.965-0.975 
02.217 
 
12-alpha-Santalen-14-ol 
OH
 
3006 
74 
115-71-9 
Liquid 
C15H24O 
220.36 
Insoluble 
Soluble 
302 
 
MS 
95 % 
1.498-1.509 
0.965-0.975 
09.034 
985 
Santalyl acetate 
O
O
O
O
 
3007 
224 
1323-00-8 
Liquid 
C17H26O2 
262.40 
Insoluble 
Miscible 
20.8 (4 hPa) 
 
IR 
95 % 
1.485-1.493 
0.980-0.986 
09.712 
1022 
Santalyl phenylacetate 
O
O
O
O
 
3008 
239 
1323-75-7 
Liquid 
C23H30O2 
338.49 
 
 
328 
 
NMR 
98 % 
1.525-1.576 
1.022-1.029 
09.809 
 
p-Mentha-1,8(10)-dien-9-yl 
acetate 
O
O
 
 
10743 
15111-97-4 
Liquid 
C12H18O2 
194.27 
Practically insoluble or 
insoluble 
Freely soluble 
218 
 
MS 
95 % 
1.473-1.479 
0.971-0.977 
09.931 
1226 
2,6-Dimethyl-2,5,7-
octatriene-1-ol acetate 
O
O
 
3886 
 
999999-91-4 
Liquid 
C12H18O2 
194.28 
Insoluble 
Soluble 
70 (3 hPa) 
 
MS 
1.490-1.500 
0.937-0.947 
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Table 2:  Specification Summary (JECFA, 2002b) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
96 % 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) Stereoisomeric composition not specified. 
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CURRENT SAFETY EVALUATION STATUS APPLYING THE PROCEDURE (BASED ON THE MSDI APPROACH)  
Table 3:  Summary of Safety Evaluation of the JECFA Substances in FGE.207 (JECFA, 2002a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
( g/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
JECFA Outcome on 
the named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(genotoxicity) 
09.034 
985 
Santalyl acetate 
O
O
O
O
 
ND 
0.01 
Class I 
A3: Intake below threshold 
4) Evaluated in FGE.207,  
no genotoxicity concern, 
to be evaluated through 
the Procedure. 
 
09.712 
1022 
Santalyl phenylacetate 
O
O
O
O
 
ND 
1 
Class I 
A3: Intake below threshold 
4) Evaluated in FGE.207,  
no genotoxicity concern, 
to be evaluated through 
the Procedure. 
 
09.931 
1226 
2,6-Dimethyl-2,5,7-
octatriene-1-ol acetate 
O
O
 
1.2 
7.7 
Class I 
A3: Intake below threshold 
4) Evaluated in 
FGE.201Rev1, additional 
genotoxicity data 
required. New data 
evaluated in FGE.207, no 
genotoxicity concern, to 
be evaluated through the 
Procedure. 
02.122 
 
p-Mentha-1,8(10)-dien-9-ol 
HO
 
0.012 
 
Class I 
No evaluation 
Not evaluated by the 
JECFA 
Evaluated in FGE.207, 
additional genotoxicity 
data required 
02.216 
 
12-beta-Santalen-14-ol 
OH
 
0.085 
 
Class I 
No evaluation 
Not evaluated by the 
JECFA 
Evaluated in FGE.207, no 
genotoxicity concern, to 
be evaluated through the 
Procedure. 
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Table 3:  Summary of Safety Evaluation of the JECFA Substances in FGE.207 (JECFA, 2002a) 
FL-no 
JECFA-no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
( g/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
JECFA Outcome on 
the named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(genotoxicity) 
09.809 
 
p-Mentha-1,8(10)-dien-9-yl 
acetate 
O
O
 
0.012 
 
Class I 
No evaluation 
Not evaluated by the 
JECFA 
Evaluated in FGE.207, 
additional genotoxicity 
data required. 
02.217 
 
12-alpha-Santalen-14-ol 
OH
 
0.11 
 
 
No evaluation 
Not evaluated by the 
JECFA 
Evaluated in FGE.207, no 
genotoxicity concern, to 
be evaluated through the 
Procedure. 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
ND: not determined 
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GENOTOXICITY (IN VITRO)  
Table 4:  Summary of Additionally Genotoxicity Data for [FL-no: 09.931] of Subgroup 1.1.2 
Chemical Name 
[FL-no:] 
Test System 
in vitro  
Test Object  Concentrations of 
Substance and Test 
Conditions  
Result  Reference  Comments  
2,6-Dimethyl-2,5,7-
octatriene-1-ol acetate 
[09.931] 
Reverse 
Mutation 
S. typhimurium TA98, 
TA100, TA1535, 
TA1537 and TA102 
 
5 - 1500 μg/plate 
[1,3]; 
5 - 5000 μg/plate 
[2,3] 
 
Negative 
[1,3]; 
Equivocal 
[2,3] 
(King, 2000) Reliable without restriction. GLP study in 
compliance with OECD Guideline 471. A small 
increase in TA102 revertant numbers was seen 
at 15 and 50 μg/plate in the presence of S9-mix, 
but not at higher concentrations. 
S. typhimurium TA98, 
TA100, TA1535, 
TA1537 and TA102 
 
5 - 1500 μg/plate 
[1,3]; 
5 - 5000 μg/plate 
[2,3] 
 
Negative 
[1,3]; 
Negative 
[2,3] 
The small increase in TA102 revertant numbers 
seen in the first experiment at 15 and 50 
μg/plate in the presence of S9-mix was not 
reproduced in the second experiment. 
S. typhimurium TA102 5 - 1500 μg/plate 
[2,3] 
 
Negative The small increase in TA102 revertant numbers 
seen in the first experiment at 15 and 50 
μg/plate in the presence of S9-mix was not 
reproduced in the third experiment. 
Micronucleus 
Assay 
Human peripheral blood 
lymphocytes (Male 
Donors) 
70 - 120 μg/ml 
 [1,4]; 
120 - 225 μg/mL 
[2,4]; 
20 - 60 μg/mL  
[1,5]; 
119.2 - 290 μg/mL 
[2,4] 
Weak positive 
+S9; 
Re-test within 
normal values 
(Whitwell, 2012) Reliable without restriction. GLP study in 
compliance with OECD Guideline 487. Weak 
evidence of inducing micronuclei in the 
presence of S9-mix in a first experiment 
(increases only in one culture). A re-test under 
the same conditions and using a higher top 
concentration resulted in MNBN frequencies 
within the historical negative control range at 
95th percentile,  but were statistically significant 
due to low vehicle control values.  
[1] Without S9-mix metabolic activation. 
[2] With S9-mix metabolic activation. 
[3] Plate incorporation method. 
[4] 3-hour incubation with 21-hour recovery period. 
[5] 24-hour incubation with no recovery period. 
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ABBREVIATIONS 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CoE  Council of Europe 
EFSA  The European Food Safety Authority 
EU  European Union 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good Laboratory Practice 
ID  Identity 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MNBN  MicroNucleated BiNucleate cells 
MS  Masse spectra 
NMR  Nuclear Magnetic Resonance 
No  Number 
OECD  Organisation for Economic Co-operation and Development 
(Q)SAR (Quantitative ) Structure Activity Relationship 
RI  Replication Index 
WHO  World Health Organisation 
